Philip Brainin1, Kristoffer Grundtvig Skaarup2, Allan Zeeberg Iversen2, Peter Godsk Jørgensen2, Elke Platz3, Jan Skov Jensen2, Tor Biering-Sørensen2. 1. Department of Cardiology, Herlev and Gentofte Hospital, Copenhagen University, Denmark; Department of Emergency Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, USA. Electronic address: denlillefilur@hotmail.com. 2. Department of Cardiology, Herlev and Gentofte Hospital, Copenhagen University, Denmark. 3. Department of Emergency Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, USA.
Abstract
BACKGROUND: Post-systolic shortening (PSS) is a novel echocardiographic marker of myocardial dysfunction. Our objective was to assess the prognostic value of PSS in patients following acute coronary syndrome (ACS) who underwent percutaneous coronary intervention (PCI). METHODS: A total of 428 patients hospitalized for ACS (mean age 64 ± 12 years, male 73%) underwent speckle tracking echocardiography following treatment with PCI (median 2 days). The individual endpoints were heart failure (HF), myocardial infarction (MI) and all-cause death. We excluded known HF. Presence of PSS was defined as post-systolic displacement ≥20% of maximum strain in one cardiac cycle. The post-systolic index (PSI) was defined as (100 × [maximum-strain cardiac cycle - peak-systolic strain])/(maximum-strain cardiac cycle)]. RESULTS: During median follow-up of 3.7 years (IQR 0.3, 5.2), 155 patients (36%) experienced HF, 52 (12%) had MI and 87 (20%) died from all causes. Patients experiencing HF had more walls displaying PSS (3.2 vs. 1.9 walls) and higher PSI (22% vs. 12%) (P < 0.001 both). In Cox proportional hazards models adjusted for baseline characteristics, invasive and echocardiographic measurements, the risk of HF increased incrementally with increasing number of walls with PSS (HR 1.28 95%CI 1.12-1.46, P < 0.001 per 1 increase in walls with PSS). The PSI remained an independent predictor of HF after adjustment (HR 1.61 95%CI 1.21-2.12, P = 0.001 per 1% increase). In the same adjusted models, MI and all-cause death were not significantly associated with PSS. CONCLUSION: Presence of PSS provides novel and independent prognostic information regarding the risk of future HF in patients with ACS following PCI.
BACKGROUND: Post-systolic shortening (PSS) is a novel echocardiographic marker of myocardial dysfunction. Our objective was to assess the prognostic value of PSS in patients following acute coronary syndrome (ACS) who underwent percutaneous coronary intervention (PCI). METHODS: A total of 428 patients hospitalized for ACS (mean age 64 ± 12 years, male 73%) underwent speckle tracking echocardiography following treatment with PCI (median 2 days). The individual endpoints were heart failure (HF), myocardial infarction (MI) and all-cause death. We excluded known HF. Presence of PSS was defined as post-systolic displacement ≥20% of maximum strain in one cardiac cycle. The post-systolic index (PSI) was defined as (100 × [maximum-strain cardiac cycle - peak-systolic strain])/(maximum-strain cardiac cycle)]. RESULTS: During median follow-up of 3.7 years (IQR 0.3, 5.2), 155 patients (36%) experienced HF, 52 (12%) had MI and 87 (20%) died from all causes. Patients experiencing HF had more walls displaying PSS (3.2 vs. 1.9 walls) and higher PSI (22% vs. 12%) (P < 0.001 both). In Cox proportional hazards models adjusted for baseline characteristics, invasive and echocardiographic measurements, the risk of HF increased incrementally with increasing number of walls with PSS (HR 1.28 95%CI 1.12-1.46, P < 0.001 per 1 increase in walls with PSS). The PSI remained an independent predictor of HF after adjustment (HR 1.61 95%CI 1.21-2.12, P = 0.001 per 1% increase). In the same adjusted models, MI and all-cause death were not significantly associated with PSS. CONCLUSION: Presence of PSS provides novel and independent prognostic information regarding the risk of future HF in patients with ACS following PCI.
Authors: Bjørnar Grenne; Christian Eek; Benthe Sjøli; Thomas Dahlslett; Michael Uchto; Per K Hol; Helge Skulstad; Otto A Smiseth; Thor Edvardsen; Harald Brunvand Journal: Heart Date: 2010-07-18 Impact factor: 5.994
Authors: Tomasz Kukulski; Fadi Jamal; Lieven Herbots; Jan D'hooge; Bart Bijnens; Liv Hatle; Ivan De Scheerder; George R Sutherland Journal: J Am Coll Cardiol Date: 2003-03-05 Impact factor: 24.094
Authors: Thomas Kümler; Gunnar Hilmar Gislason; Vibeke Kirk; Morten Bay; Olav W Nielsen; Lars Køber; Christian Torp-Pedersen Journal: Eur J Heart Fail Date: 2008-06-09 Impact factor: 15.534